Jaclyn Hastings, MD
Family Medicine · Boston, MANPI 1821523994
Payments from drug & device makers
Across 60 payments — averaging $17.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$302
- Pfizer$78
- Lilly USA, LLC$74
- Takeda Pharmaceuticals U.S.A., Inc.$69
- Kyowa Kirin, Inc.$65
- GSK$53
- plus $394 from 15 others
What the payments were for
- Food & beverage$1,035100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $302 |
| Pfizer | 3 | $78 |
| Lilly USA, LLC | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $69 |
| Kyowa Kirin, Inc. | 3 | $65 |
| GSK | 4 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Johnson & Johnson | 3 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| AstraZeneca | 3 | $38 |
| Neurocrine Biosciences, Inc. | 2 | $32 |
| Boehringer Ingelheim | 2 | $29 |
| Abbott | 1 | $23 |
| Bayer | 1 | $20 |
| Indivior Inc. | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $11 |
How this compares
$1,035 in reported general payments places this provider in the 85th percentile of 1,049 family medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 13 | $162 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Boston
- Katherine Gergen BarnettBoston$226K
- Peter O'DwyerBoston$163K
- Larry CulpepperBoston$109K
- Suzanne MitchellBoston$69K
- Michael LowneyBoston$13K
- Renee CrichlowBoston$5K
- Robert BeckWestford$2.1M
- Kelly LannuttiWeymouth$122K
- Jennifer WeylerWorcester$105K
- Megan McCoyFramingham$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.